New hope for liver cancer patients out of standard options
NCT ID NCT07377487
Summary
This study is testing a device called BSJ019T (TheraSphere) in Japanese patients with liver cancer that cannot be removed by surgery and who have run out of or cannot receive standard treatments. The device delivers tiny radioactive beads directly to liver tumors through the blood vessels. Researchers want to see if this approach is safe and can help control the cancer's growth in the liver.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LIVER NEOPLASMS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hyogo College of Medicine Hospital
NOT_YET_RECRUITINGNishinomiya, Hyōgo, 663-8501, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Kanazawa University Hospital
RECRUITINGKanazawa, Ishikawa-ken, 920-8641, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Kindai University Hospital
NOT_YET_RECRUITINGSayama, Osaka, 589-8511, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
National Cancer Center Hospital
NOT_YET_RECRUITINGChuo Ku, Tokyo, 104-0045, Japan
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.